Spectrum Pharmaceuticals, Inc. (SPPI) Posts Mixed Q2 Results
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Financial Fact:
Total operating costs and expenses: 49.39M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total operating costs and expenses: 49.39M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q2 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $45.5 million versus the consensus estimate of $37.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
